---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-019145"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:04:18.978946+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics receives Nasdaq bid price deficiency notice; 180 days to regain compliance

## Summary
- Nasdaq notified Century Therapeutics on Feb 26, 2025 that its stock closed below $1.00 for 31 consecutive business days.
- Company has until August 25, 2025 to regain compliance by maintaining bid price of at least $1.00 for 10 consecutive days.
- If not compliant, Century may transfer to Nasdaq Capital Market for an additional 180-day cure period.
- Company plans to monitor bid price and consider options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001104659-25-019145
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465925019145/0001104659-25-019145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465925019145/tm257938d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-019145
- JSON: https://secwatch.observer/filing/0001104659-25-019145.json
- Plain text: https://secwatch.observer/filing/0001104659-25-019145.txt

## Key facts
- Listing & Compliance Notices
  Century Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: February 26, 2025, Century Therapeutics, Inc. (the “Company”) received a notification letter (the “Bid Price Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 31 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)”). The Bid Price Letter is a notice of deficiency, not delisting, and does not currently affect the listing or trading of the Company’s shares o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465925019145/0001104659-25-019145-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.